Andreas Clemens

Andreas Clemens

Novartis Institutes for BioMedical Research - Bhubaneswar / United States
Medical and Health Sciences / Endocrinology and Metabolism
AD Scientific Index ID: 4390971
-
person_outline Andreas Clemens's MOST POPULAR ARTICLES
1-) Dabigatran etexilate–a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activityJ Van Ryn, J Stangier, S Haertter, KH Liesenfeld, W Wienen, M Feuring, ...Thrombosis and haemostasis 103 (06), 1116-1127, 201017822010
2-) Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patientsAM Gallagher, E Setakis, JM Plumb, A Clemens, TP van StaaThrombosis and haemostasis 106 (11), 968-977, 20114732011
3-) Pharmacology, pharmacokinetics, and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitorJ Stangier, A ClemensClinical and applied thrombosis/hemostasis 15 (1_suppl), 9S-16S, 20093892009
4-) Warfarin treatment in patients with atrial fibrillation: observing outcomes associated with varying levels of INR controlCL Morgan, P McEwan, A Tukiendorf, PA Robinson, A Clemens, ...Thrombosis research 124 (1), 37-41, 20093952009
5-) Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options—a report from the 3rd Atrial Fibrillation Competence NETwork …P Kirchhof, GYH Lip, IC Van Gelder, J Bax, E Hylek, S Kaab, U Schotten, ...Europace 14 (1), 8-27, 20123522012